Come up with a name for your new list and we'll add to it:
Proacta raised a round of funding on February 25, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Proacta is a clinical-stage, biopharmaceutical company focused on addressing unmet needs in the field of cancer with current efforts directed towards the development of hypoxia-activated prodrugs that…